Gene expression of extracellular matrix proteoglycans in human cyclosporin-induced gingival overgrowth.
D000328:Adult; D058578:Biglycan; D011508:Chondroitin Sulfate Proteoglycans / Q000096:biosynthesis; D016572:Cyclosporine / Q000009:adverse effects*; D058575:Decorin; D016326:Extracellular Matrix Proteins / Q000096:biosynthesis*; D005260:Female; D015870:Gene Expression; D019214:Gingival Overgrowth / Q000139:chemically induced* / Q000378:metabolism*; D019812:Heparan Sulfate Proteoglycans / Q000096:biosynthesis; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000009:adverse effects; D037181:Lectins, C-Type; D016031:Liver Transplantation / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011509:Proteoglycans / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D053675:Versicans
C546884:BGN protein, human; D058578:Biglycan; D011508:Chondroitin Sulfate Proteoglycans; C546878:DCN protein, human; D058575:Decorin; D016326:Extracellular Matrix Proteins; D019812:Heparan Sulfate Proteoglycans; D007166:Immunosuppressive Agents; D037181:Lectins, C-Type; D011509:Proteoglycans; D012333:RNA, Messenger; C508322:VCAN protein, human; D053675:Versicans; C071927:perlecan; D016572:Cyclosporine